Replies to post #194706 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

The FDA grants priority review to medicines that have the potential to provide significant improvements in the treatment of a serious disease, and the designation shortens the review period to six months from the standard 10 months

Wow, they move at warp speed to get it done in 6 months. Note to self: Do not call the FDA if you are bleeding. Seriously???